| UniProt/SwissProt ID: | 4F2_HUMAN |
| Description: | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 [Source:HGNC Symbol;Acc:11026] |
| Location: | chr11 q12.3 |
| Node attribute: | gene |
| Phosphorylation site |
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|---|---|---|
| S2 | DTEV | HPRD; phosphoELM; SysPTM | |
| Y312 | DLTPNyRGENS | HPRD | |
| S200 | SAKKKsIRVIL | HPRD | |
| T5 | VDMK | HPRD; phosphoELM; SysPTM | |
| S165 | KFTGLsKEELL | PhosphoSitePlus | |
| S545 | GREEGsPLELE | HPRD | |
| Y250 | DLTPNyRGENS | HPRD | |
| S506 | GREEGsPLELE | HPRD | |
| S527 | LFRRLsDQRSK | DUF3459 | PhosphoSitePlus |
| S239 | SAKKKsIRVIL | HPRD | |
| T162 | AAAKFtGLSKE | PhosphoSitePlus | |
| S607 | GREEGsPLELE | HPRD | |
| T321 | NSWFStQVDTV | Alpha-amylase | PhosphoSitePlus |
| S410 | LSDSGsTGEHT | PhosphoSitePlus | |
| S72 | SGAAMsLAGAE | HPRD | |
| Y211 | DLTPNyRGENS | HPRD | |
| S406 | TSSYLsDSGST | PhosphoSitePlus | |
| S33 | SGAAMsLAGAE | HPRD; SysPTM | |
| S9 | QPPEAsIAVVS | PhosphoSitePlus; HPRD | |
| T106 | TMSQDtEVDMK | PhosphoSitePlus; HPRD | |
| S103 | VTGTMsQDTEV | PhosphoSitePlus; HPRD | |
| S607 | GREEGsPLELE | DUF3459 | PhosphoSitePlus |
| S320 | ENSWFsTQVDT | Alpha-amylase | PhosphoSitePlus |
| S134 | SGAAMsLAGAE | PhosphoSitePlus; HPRD | |
| T44 | TMSQDtEVDMK | HPRD | |
| S531 | LSDQRsKERSL | DUF3459 | PhosphoSitePlus |
| S408 | SYLSDsGSTGE | PhosphoSitePlus | |
| S301 | SAKKKsIRVIL | HPRD | |
| S41 | DSGTMsQDTEV | HPRD | |
| Dephosphorylation site |
| 4F2_HUMAN do not have dephosphorylation site. |
| Mutation site |
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|---|---|---|---|
| ENSP00000367124 | S552F | COSMIC | Skin Cancer | 21984974 |
| Differential expressed protein |
| Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
|---|---|---|---|---|---|---|
| ENSP00000367124 | Hepatocellular Carcinoma | Normal vs. Cancer | cell line | Down | 0.17 | 18646787 |
| ENSP00000367124 | Hepatocellular Carcinoma | Normal vs. Cancer | cell line | Down | 0.31 | 18646787 |
| ENSP00000367124 | Breast Cancer | Treatment (mitoxantrone-sensitive vs. mitoxantrone-resistant) | cell line | Up | 4.4 | 16335961 |
| ENSP00000367124 | Breast Cancer | Metastasis | cell line | Down | 0.43 | 18729497 |
| ENSP00000367124 | Breast Cancer | Metastasis | cell line | Down | 0.45 | 18729497 |
| ENSP00000367124 | Breast Cancer | Metastasis | cell line | Down | 0.5 | 19321434 |
| ENSP00000367124 | Breast Cancer | Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) | tissue | Up | 1.8 | 19329653 |
| ENSP00000367124 | Leukemia | Cancer vs. Cancer (chronic vs. acute leukemia) | cell line | Down | 17449014 | |
| Hyperphosphorylation site |
| 4F2_HUMAN do not have hyperphosphorylation site. |
| Direct Interaction Pair |
| Source | Target | Relationship | Resource |
|---|---|---|---|
| JUN_HUMAN | 4F2_HUMAN | TF -> target gene | TRANSFAC |
| Function Annotation |
| KEGG Pathway |
| 4F2_HUMAN is not in KEGG pathway. |
| Gene Ontology |
| GO ID | GO_Term | Evidence | Ontology |
|---|---|---|---|
| GO:0006865 | amino acid transport | TAS | biological_process |
| GO:0003824 | catalytic activity | IEA | molecular_function |
| GO:0007596 | blood coagulation | TAS | biological_process |
| GO:0005515 | protein binding | IPI | molecular_function |
| GO:0005886 | plasma membrane | TAS | cellular_component |
| GO:0060356 | leucine import | IEA | biological_process |
| GO:0016049 | cell growth | NAS | biological_process |
| GO:0042470 | melanosome | IEA | cellular_component |
| GO:0016021 | integral to membrane | NAS | cellular_component |
| GO:0006811 | ion transport | TAS | biological_process |
| GO:0016324 | apical plasma membrane | IEA | cellular_component |
| GO:0006816 | calcium ion transport | NAS | biological_process |
| GO:0015175 | neutral amino acid transmembrane transporter activ | IEA | molecular_function |
| GO:0050900 | leukocyte migration | TAS | biological_process |
| GO:0043169 | cation binding | IEA | molecular_function |
| GO:0005975 | carbohydrate metabolic process | IEA | biological_process |
| GO:0005432 | calcium:sodium antiporter activity | TAS | molecular_function |
| GO:0055085 | transmembrane transport | TAS | biological_process |
| GO:0015827 | tryptophan transport | ISS | biological_process |
| GO:0009986 | cell surface | IDA | cellular_component |